Related Experiment Video
Updated: Dec 9, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Clinical Research after COVID-19: Embracing a New Normal
Joel M Gelfand1, Brooke E Hefele2
1Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
The COVID-19 pandemic disrupted dermatology clinical trials for psoriasis and other conditions. Researchers must adapt trial procedures to ensure patient safety and maintain scientific integrity amid the pandemic.
Area of Science:
- Dermatology
- Clinical Research
- Infectious Diseases
Background:
- The COVID-19 pandemic has significantly impacted global public health and daily life.
- Clinical trials in dermatology, specifically for conditions like psoriasis, atopic dermatitis, and hidradenitis, have faced numerous disruptions, including suspension and termination.
- The pandemic necessitates a re-evaluation of standard research protocols.
Purpose of the Study:
- To highlight the impact of the COVID-19 pandemic on dermatology clinical trials.
- To emphasize the need for clinical investigators to adapt research methodologies.
- To provide guidance on maintaining scientific rigor while mitigating transmission risks.
Main Methods:
- This study reviews the effects of the COVID-19 pandemic on ongoing and planned dermatology clinical trials.
- It discusses the challenges faced by researchers in maintaining trial continuity and patient safety.
- The abstract emphasizes the need for adaptive strategies in clinical research during a pandemic.
Main Results:
- Dermatology clinical trials for psoriasis, atopic dermatitis, and hidradenitis have been significantly disrupted.
- There is an urgent need for clinical investigators to adopt new procedures.
- Mitigating transmission of severe acute respiratory syndrome coronavirus 2 and conserving personal protective equipment are key challenges.
Conclusions:
- Clinical investigators must embrace a "new normal" to navigate the COVID-19 pandemic.
- Adapting research procedures is crucial for the continuation of dermatology clinical trials.
- Maintaining scientific rigor while ensuring safety and resource management is paramount.
Related Concept Videos
Ethics in Research
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Bioavailability Study Design: Healthy Subjects Versus Patients
Controls in Experiments

